日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Eptinezumab to prevent difficult-to-treat migraine: prospective, six-month, real-world multicenter evidence from the GRASP study group

Eptinezumab 预防难治性偏头痛:来自 GRASP 研究组的前瞻性、六个月、真实世界多中心证据

Dermitzakis, Emmanouil V; Argyriou, Andreas A; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Athanasopoulos, Dimitrios; Tsironis, Christos; Soldatos, Panagiotis; Koutsokera, Maria; Tsitsaras, Nikolaos; Litsardopoulos, Pantelis; Mavraki, Eleni; Vikelis, Michail

COVID-19's Impact on Health Professionals' Quality of Professional Life: A Single-Site Cross-Sectional Study

COVID-19 对医护人员职业生活质量的影响:一项单中心横断面研究

Rovithis, Michael; Koukouli, Sofia; Konstantinou, Anastasia; Moudatsou, Maria; Rikos, Nikos; Linardakis, Manolis; Piliotis, Konstantinos; Stavropoulou, Areti

OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group

使用A型肉毒杆菌毒素预防伴有磨牙症的慢性偏头痛:来自GRASP研究组的真实世界数据

Argyriou, Andreas A; Dermitzakis, Emmanouil V; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Xiromerisiou, Georgia; Soldatos, Panagiotis; Litsardopoulos, Pantelis; Vikelis, Michail

Gender and age effects on the incidence and severity of chemotherapy-induced neuropathic pain: a propensity score matching analysis

性别和年龄对化疗诱发神经性疼痛发生率和严重程度的影响:倾向评分匹配分析

Argyriou, Andreas A; Velasco, Roser; Kalofonou, Foteini; Litsardopoulos, Pantelis; Alemany, Montse; Rikos, Dimitrios; Kalofonos, Haralabos P; Bruna, Jordi

Testing the Efficacy of Eptinezumab 100 mg in the Early Prevention of Chronic Migraine over Weeks 1 to 4: Prospective Real-World Data from the GRASP Study Group

在第 1 至 4 周内测试 Eptinezumab 100 mg 在慢性偏头痛早期预防中的疗效:来自 GRASP 研究组的前瞻性真实世界数据

Argyriou, Andreas A; Dermitzakis, Emmanouil V; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Soldatos, Panagiotis; Vikelis, Michail

Efficacy of single-dose galcanezumab 240 mg on episodic or refractory chronic cluster headache: prospective, 4-week, real-world evidence from the GRASP study group

单剂量 240 mg 加尔卡奈珠单抗治疗发作性或难治性慢性丛集性头痛的疗效:来自 GRASP 研究组的前瞻性、4 周真实世界证据

Vikelis, Michail; Argyriou, Andreas A; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Tsironis, Christos; Soldatos, Panagiotis; Koutsokera, Maria; Dermitzakis, Emmanouil V

Network-Based Epidemic Control Through Optimal Travel and Quarantine Management

通过优化旅行和隔离管理实现基于网络的疫情控制

Talaei, Mahtab; Rikos, Apostolos I; Olshevsky, Alex; White, Laura F; Paschalidis, Ioannis Ch

High School Teachers' Awareness of Internet Addiction and Related Factors Among Greek Adolescent Students

希腊高中教师对青少年网络成瘾及相关因素的认识

Vlachopoylos, Nikolaos; Mantadaki, Aikaterinh E; Moyrelloy, Evangelia; Volkos, Panagiotis; Smyrnakis, Emmanouil; Ramoutsaki, Ioanna; Pitsoulis, Georgios; Papadakis, Antonios; Koutentaki, Efi; Kamekis, Apostolos; Linardakis, Manolis; Rikos, Nikos; Symvoulakis, Emmanouil K

Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine

肉毒杆菌毒素A对慢性偏头痛患者的痛觉过敏和发作间期负担的影响

Argyriou, Andreas A; Dermitzakis, Emmanouil V; Rikos, Dimitrios; Xiromerisiou, Georgia; Soldatos, Panagiotis; Litsardopoulos, Pantelis; Vikelis, Michail

Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options

2023年针对2565名希腊偏头痛患者的网络调查结果:人口统计学数据、患者负担以及在新治疗方案时代对急性期和预防性治疗的满意度

Dermitzakis, Emmanouil V; Argyriou, Andreas A; Bilias, Konstantinos; Barmpa, Evangelia; Liapi, Sofia; Rikos, Dimitrios; Xiromerisiou, Georgia; Soldatos, Panagiotis; Vikelis, Michail